Saltar al contenido
Merck

P38706

Sigma-Aldrich

Phthalazine

98%

Sinónimos:

β-Phenodiazine, 2,3-Benzodiazine, 2,3-Diazanaphthalene, Benzo[d]pyridazine

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula empírica (notación de Hill):
C8H6N2
Número de CAS:
Peso molecular:
130.15
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Quality Level

assay

98%

form

crystals

bp

189 °C/29 mmHg (lit.)

mp

89-92 °C (lit.)

storage temp.

2-8°C

SMILES string

c1ccc2cnncc2c1

InChI

1S/C8H6N2/c1-2-4-8-6-10-9-5-7(8)3-1/h1-6H

InChI key

LFSXCDWNBUNEEM-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

pictograms

Health hazard

signalword

Warning

hcodes

Hazard Classifications

Aquatic Chronic 3 - Muta. 2

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Hyungchul Kim et al.
International journal of pharmaceutics, 377(1-2), 105-111 (2009-05-26)
Investigation of the use of solution NMR spectroscopy to determine the effect of organic solvents on chemical shift changes in bases on addition of acids is reported. This information can be useful in the evaluation of solvents and counterion selection
R S K Vijayan et al.
Journal of molecular graphics & modelling, 27(3), 286-298 (2008-06-21)
Given the heterogeneity of GABA(A) receptor, the pharmacological significance of identifying subtype selective modulators is increasingly being recognized. Thus, drugs selective for GABA(A) alpha(3) receptors are expected to display fewer side effects than the drugs presently in clinical use. Hence
Brad Herberich et al.
Journal of medicinal chemistry, 51(20), 6271-6279 (2008-09-27)
Investigations into the structure-activity relationships (SAR) of a series of phthalazine-based inhibitors of p38 are described. These efforts originated from quinazoline 1 and through rational design led to the development of a series of orally bioavailable, potent, and selective inhibitors.
Jin Sung Kim et al.
Bioorganic & medicinal chemistry, 16(8), 4545-4550 (2008-03-07)
Studies on antitumor heterocyclic quinones containing nitrogens revealed that the number and position of nitrogens on the heterocyclic ring have significance on cytotoxicity of quinones. In our continuous effort to find more cytotoxic quinone compounds, we designed triazolophthalazine analogues in
Panayiotis A Procopiou et al.
Journal of medicinal chemistry, 54(7), 2183-2195 (2011-03-09)
A series of potent phthalazinone-based human H(1) and H(3) bivalent histamine receptor antagonists, suitable for intranasal administration for the potential treatment of allergic rhinitis, were identified. Blockade of H(3) receptors is thought to improve efficacy on nasal congestion, a symptom

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico